These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23787547)

  • 1. Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
    Wysocki J; Batlle D
    Nephrol Dial Transplant; 2013 Sep; 28(9):2200-2. PubMed ID: 23787547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease.
    Roberts MA; Velkoska E; Ierino FL; Burrell LM
    Nephrol Dial Transplant; 2013 Sep; 28(9):2287-94. PubMed ID: 23535224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease.
    Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Mojal S; Fernández E; Soler MJ;
    Nephrol Dial Transplant; 2015 Jul; 30(7):1176-85. PubMed ID: 25813276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.
    Wolke C; Teumer A; Endlich K; Endlich N; Rettig R; Stracke S; Fiene B; Aymanns S; Felix SB; Hannemann A; Lendeckel U
    Exp Biol Med (Maywood); 2017 Mar; 242(5):554-563. PubMed ID: 28038565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease.
    Trojanowicz B; Imdahl T; Ulrich C; Fiedler R; Girndt M
    Nephron; 2019; 141(1):61-74. PubMed ID: 30326474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease.
    Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Clotet S; Mojal S; Fernández E; Soler MJ;
    Atherosclerosis; 2016 Oct; 253():135-143. PubMed ID: 27615597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenal distributions and changes of Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 in feline and canine chronic kidney disease.
    Mitani S; Yabuki A; Sawa M; Chang HS; Yamato O
    J Vet Med Sci; 2014 Jan; 76(1):45-50. PubMed ID: 24004970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study.
    Shi C; Lu K; Xia H; Zhang P; Zhang B
    Medicine (Baltimore); 2020 Jul; 99(31):e21492. PubMed ID: 32756181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling.
    Walters TE; Kalman JM; Patel SK; Mearns M; Velkoska E; Burrell LM
    Europace; 2017 Aug; 19(8):1280-1287. PubMed ID: 27738071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
    Novo S; Adamo L; Forte G; Galfano G; Giamporcaro A; Ferrara D; Strano A
    Cardiologia; 1985 Jul; 30(7):505-10. PubMed ID: 3011264
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.
    Ohashi N; Isobe S; Ishigaki S; Suzuki T; Ono M; Fujikura T; Tsuji T; Kato A; Ozono S; Yasuda H
    Hypertens Res; 2017 Apr; 40(4):364-370. PubMed ID: 27761002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating angiotensin-converting enzyme 2 activity in kidney transplantation: a longitudinal pilot study.
    Soler MJ; Riera M; Crespo M; Mir M; Márquez E; Pascual MJ; Puig JM; Pascual J
    Nephron Clin Pract; 2012; 121(3-4):c144-50. PubMed ID: 23257682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary angiotensin-converting enzyme 2 in patients with CKD.
    Mizuiri S; Aoki T; Hemmi H; Arita M; Sakai K; Aikawa A
    Nephrology (Carlton); 2011 Aug; 16(6):567-72. PubMed ID: 21457402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of leucocytic angiotensin-converting enzymes expression in patients maintained on high-permeable haemodialysis.
    Trojanowicz B; Ulrich C; Fiedler R; Martus P; Storr M; Boehler T; Werner K; Hulko M; Zickler D; Willy K; Schindler R; Girndt M
    Nephrol Dial Transplant; 2018 Jan; 33(1):34-43. PubMed ID: 28992224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney ACE2 expression: Implications for chronic kidney disease.
    Maksimowski N; Williams VR; Scholey JW
    PLoS One; 2020; 15(10):e0241534. PubMed ID: 33125431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
    Xiao F; Hiremath S; Knoll G; Zimpelmann J; Srivaratharajah K; Jadhav D; Fergusson D; Kennedy CR; Burns KD
    PLoS One; 2012; 7(5):e37649. PubMed ID: 22629438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiotensin converting enzyme activity in patients with chronic renal failure on long term hemodialysis.
    Patel R; Ansari A
    Clin Chim Acta; 1979 Mar; 92(3):491-5. PubMed ID: 219970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Angiotensin-Converting Enzyme 2 and Coronary Artery Calcification in Patients on Maintenance Hemodialysis Therapy.
    Zhang Q; Sun L; Jin L
    Ther Apher Dial; 2015 Oct; 19(5):466-70. PubMed ID: 26112236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
    Ye M; Wysocki J; Gonzalez-Pacheco FR; Salem M; Evora K; Garcia-Halpin L; Poglitsch M; Schuster M; Batlle D
    Hypertension; 2012 Sep; 60(3):730-40. PubMed ID: 22777933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.